PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs
- 1 March 1997
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 2 (3) , 89-101
- https://doi.org/10.1016/s1359-6446(97)01000-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Identification of cyclic AMP‐phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cellsFEBS Letters, 1996
- Biarylcarboxylic Acids and -amides: Inhibition of Phosphodiesterase Type IV versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the FerretJournal of Medicinal Chemistry, 1996
- Expression and regulation of human and rat phosphodiesterase type IV isogenesFEBS Letters, 1994
- Rolipram, but not siguazodan or zaprinast, inhibits the excitatory noncholinergic neurotransmission in guinea-pig bronchiEuropean Respiratory Journal, 1994
- Effects of solubilization and vanadate/glutathione complex on inhibitor potencies against eosinophil cyclic AMP‐specific phosphodiesteraseFEBS Letters, 1992
- Characterization of the memory gene dunce of Drosophila melanogasterJournal of Molecular Biology, 1991
- Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with ImipraminePharmacopsychiatry, 1989
- Purification of cAMP-specific phosphodiesterase from rat heart by affinity chromatography on immobilized rolipramBiochemical and Biophysical Research Communications, 1986
- On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter.Thorax, 1985
- Defect in cyclic AMP phosphodiesterase due to the dunce mutation of learning in Drosophila melanogasterNature, 1981